Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the recipient of a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 22,782 shares, a drop of 55.5% from the June 15th total of 51,245 shares. Currently, 1.1% of the company’s stock are short sold. Based on an average daily volume of 35,607 shares, the short-interest ratio is presently 0.6 days.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in FFTY. Kestra Advisory Services LLC acquired a new position in shares of Innovator IBD 50 ETF during the fourth quarter worth $72,000. Jane Street Group LLC acquired a new stake in Innovator IBD 50 ETF in the fourth quarter valued at $282,000. Simplex Trading LLC acquired a new stake in Innovator IBD 50 ETF in the fourth quarter valued at $41,000. Advisory Services Network LLC purchased a new stake in Innovator IBD 50 ETF during the 3rd quarter worth about $43,000. Finally, Bank of America Corp DE boosted its position in shares of Innovator IBD 50 ETF by 307.2% during the 2nd quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock worth $404,000 after acquiring an additional 9,391 shares in the last quarter.
Innovator IBD 50 ETF Stock Down 2.7%
NYSEARCA FFTY traded down $1.07 during trading hours on Thursday, hitting $38.50. 15,508 shares of the company were exchanged, compared to its average volume of 67,785. The company has a 50 day moving average of $41.04 and a two-hundred day moving average of $38.35. The firm has a market cap of $82.78 million, a price-to-earnings ratio of 30.34 and a beta of 1.45. Innovator IBD 50 ETF has a 52-week low of $31.61 and a 52-week high of $44.08.
About Innovator IBD 50 ETF
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
